Drug Discovery Biology

Uncovering the secrets of the human body

About us

Find out more about the Drug Discovery Biology theme.

Research labs

Our research groups are supported by government grant schemes and key industry partnerships, and collaborate extensively with national and international researchers.

Therapeutic areas

Learn about the five therapeutic areas that underpin the focus of our research.

PhD program

Discover what a higher degree with us entails and find out about available projects.

Research capabilities

Learn more about the techniques we employ.

Find a researcher

Build a collaboration



Contact us

For any enquiries please contact +61 3 9903 9614 or pharm-ddbenquiries@monash.edu.

Other research themes

See the latest news

Monash scientists expose tumour-causing protein

Monash University scientists have discovered the structure of the protein behind neurofibromatosis type 1 (NF1), a common genetic condition that causes tumours to form on nerve tissue.
10 December, 2021 Medicine & health

Monash launches new Neuromedicines Discovery Centre to transform treatments for mental health disorders

Monash University today will launch an end-to-end, cross-disciplinary Centre to drive novel psychiatric drug discovery, as well as new approaches to neuromedicine-assisted psychotherapies, for the treatment of mental health disorders.
10 November, 2021

MIPS researchers receive nearly $3.5M in NHMRC Ideas Grants

Funding through the Commonwealth Government’s National Health and Medical Research Council (NHMRC) has been announced, with the Monash Institute of Pharmaceutical Sciences (MIPS) successful in grants totalling close to $3.5 million.
4 November, 2021

“Sweet death”: Review highlights the dangers of high-fructose consumption

Monash University researcher and collaborator in the US published a review summarising recent studies on fructose and how high consumption of fructose leads to certain “lifestyle diseases”.
14 October, 2021

Monash University researchers paves way to the development of non-opioid painkillers to treat chronic pain

Monash University researchers have made a breakthrough discovery that could pave the way for the development of novel non-opioid painkillers (analgesics) to safely and effectively treat neuropathic pain.
9 September, 2021 Research
Young person placing medication in the palms of elderly person in long blue sleeves

MIPS researchers receive MRFF funding to accelerate discovery research projects

Researchers from the Monash Institute of Pharmaceutical Sciences (MIPS) are leading, or playing an integral role, in a number of projects which have received funding from the Commonwealth Government’s Medical Research Future Fund (MRFF).
2 July, 2021 Research

Scientists develop novel tools to gain new insights into an important therapeutic target

A team of researchers, led by the Monash Institute of Pharmaceutical Sciences (MIPS) have, for the first time, developed a tool that will enable the wider scientific community to gain a deeper understanding of how the human adenosine A1 receptor
7 June, 2021 Research
Model diseased heart

Australian researchers drive global call to action to tackle world’s leading cause of death

A team of Australian drug researchers from Monash University, The University of Sydney and La Trobe University have led a global call to action to accelerate new approaches for cardiovascular disease (CVD) drug solutions. CVD is the leading cause of
23 April, 2021 Medicine & health

Monash University researchers discover potential therapeutic target to reduce diabetes-induced heart failure

Researchers from the Monash Institute of Pharmaceutical Sciences (MIPS), in collaboration with The Baker Heart and Diabetes Institute, have discovered a potential therapeutic target which could reduce heart failure and may improve the quality of
15 March, 2021 Research